Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours
Mahalingam, D, Wilding, G, Denmeade, S, Sarantopoulas, J, Cosgrove, D, Cetnar, J, Azad, N, Bruce, J, Kurman, M, Allgood, V E, Carducci, M
Published in British journal of cancer (26.04.2016)
Published in British journal of cancer (26.04.2016)
Get full text
Journal Article
A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma
Cavenagh, J, Oakervee, H, Baetiong-Caguioa, P, Davies, F, Gharibo, M, Rabin, N, Kurman, M, Novak, B, Shiraishi, N, Nakashima, D, Akinaga, S, Yong, K
Published in British journal of cancer (24.10.2017)
Published in British journal of cancer (24.10.2017)
Get full text
Journal Article
TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T‐CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T‐CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM A PHASE 2 STUDY
Witzig, T., Sokol, L., Kim, W., Foss, F., Jacobsen, E., Cruz Vincente, F., Caballero, D., Advani, R., Roncero Vidal, J.M., Marin‐Niebla, A., Rodriguez Izquierdo, A., Ona Navarrete, R., Terol, M.J., Domingo‐Domenech, E., Rodriguez, M., Piris, M.A., Bolognese, J., Janes, M.R., Burrows, F., Kessler, L., Mishra, V., Curry, R., Kurman, M., Scholz, C., Gualberto, A.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
601 A First-in-human, Phase 1 Clinical Study of the Safety, Tolerability and Pharmacokinetics (PK) of G-202, a Thapsigargin-based PSMA-activated Prodrug, in Patients with Advanced Solid Tumors
Mahalingam, D, Wilding, G, Denmeade, S, Sarantopoulas, J, Cosgrove, D, Cetnar, J, Azad, N, Bruce, J, Kurman, M, Carducci, M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer
Blanke, C D, Kasimis, B, Schein, P, Capizzi, R, Kurman, M
Published in Journal of clinical oncology (01.03.1997)
Published in Journal of clinical oncology (01.03.1997)
Get more information
Journal Article
GRECO-1: Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) with or without Rucosopasem (GC4711) for Early Stage, Peripheral or Centrally Located Non-Small Cell Lung Cancer (NSCLC)
Iyengar, P., Allen, B.G., Kelsey, C.R., Moser, E.C., Holm, M., Kurman, M., Holmlund, J.
Published in International journal of radiation oncology, biology, physics (01.11.2022)
Published in International journal of radiation oncology, biology, physics (01.11.2022)
Get full text
Journal Article
A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck
Hadden, J, Verastegui, E, Barrera, J.L, Kurman, M, Meneses, A, Zinser, J.W, de la Garza, J, Hadden, E
Published in International immunopharmacology (01.08.2003)
Published in International immunopharmacology (01.08.2003)
Get full text
Journal Article
1006P ACE1702, a first-in-class, off-the-shelf, selected natural killer cell [oNK] product using antibody cell conjugation technology [ACC], with pre-clinical and early clinical activity in HER2 < 3+ tumors
Piha-Paul, S.A., Mahalingam, D., Mulcahy, M.F., Kalyan, A., Li, H-K., Wu, E., Kurman, M., Lee, S., Lin, Y-L., Tang, S-W., Hsiao, C-W., Pan, J., Chien, S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
A Phase 1b/2a Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Nanogenistein in Combination with Chemoradiotherapy for Non-small Cell Lung Cancer
Simone, C.B., Movsas, B., Gore, E.M., Mohindra, P., Vujaskovic, Z., Wang, D., Ajlouni, M., Menon, S., Thompson, J., Brown, S.L., Kurman, M., Dykstra, J.C., Rillo, L., Ingram, M., Serebrenik, A., Kaytor, M.D.
Published in International journal of radiation oncology, biology, physics (01.11.2020)
Published in International journal of radiation oncology, biology, physics (01.11.2020)
Get full text
Journal Article
A Phase 1b/2a Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Nano-Genistein and Chemoradiotherapy for Non-Small Cell Lung Cancer
Kaytor, M.D., Brown, S.L., Arapi, I., Kurman, M., Dykstra, J.C., Rillo, L., Ingram, M., Poppitz, S., Menon, S., Thompson, J., Wang, D., Ajlouni, M., Gore, E.M., Movsas, B.
Published in International journal of radiation oncology, biology, physics (01.11.2018)
Published in International journal of radiation oncology, biology, physics (01.11.2018)
Get full text
Journal Article
Open-label, sequential, ascending, multi-dose, phase I study of KW-2450 as monotherapy in subjects with previously treated advanced solid tumors
Dickson, M. A., LoRusso, P., Sausville, E. A., Rao, N., Kobayashi, E., Kurman, M. R., Akinaga, S., Schwartz, G. K.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
S869 TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T‐CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T‐CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM AN OPEN‐LABEL, PHASE 2 STUDY
Witzig, T., Sokol, L., Kim, W.S., Foss, F., Jacobsen, E., Cruz Vicente, F., Caballero, D., Advani, R., Roncero Vidal, M.J., Niebla, A.M., Rodriguez Izquierdo, A., Ona Navarrete, R., Jose Terol, M., Domingo‐Domenech, E., Rodriguez, M., Piris, M., Bolognese, J., Janes, M.R., Burrows, F., Kessler, L., Mishra, V., Curry, R., Kurman, M., Scholz, C., Gualberto, A.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
A phase Ib/II, dose-escalating, safety, and efficacy study of imprime PGG and cetuximab in patients with advanced colorectal cancer (CRC)
Tamayo, M. B., Cornelio, G. H., Bautista, J. B., Flores, M. L., Tioleco, P. S., Kurman, M. R., Marsh, L. M., Gargano, M. A., Patchen, M. L.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A phase Ib/2, dose-escalating, safety, and efficacy study of imprime PGG, cetuximab and irinotecan in patients with advanced colorectal cancer (CRC)
Tamayo, M. E., Cornelio, G. H., Bautista, J. B., Flores, M. L., Kurman, M. R., Paul, M. M., Gargano, M. A., Patchen, M. L.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article